EcoDrugPlus

Fms Related Receptor Tyrosine Kinase 3

Ensembl ID : ENSSVLG00005023095
Gene Symbol: FLT3
1 Cross references
133 Possible Orthologues:

Folate Hydrolase 1

Ensembl ID : ENSSVLG00005022156
Gene Symbol: FOLH1
1 Cross references
210 Possible Orthologues:

Folate Receptor Alpha

Ensembl ID : ENSSVLG00005014547
Gene Symbol: FOLR1
1 Cross references
217 Possible Orthologues:

Follicle Stimulating Hormone Receptor

Ensembl ID : ENSSVLG00005021556
Gene Symbol: FSHR
1 Cross references
199 Possible Orthologues:

Free Fatty Acid Receptor 1

Ensembl ID : ENSSVLG00005024814
Gene Symbol: FFAR1
1 Cross references
138 Possible Orthologues:

Free Fatty Acid Receptor 2

Ensembl ID : ENSSVLG00005024856
Gene Symbol: FFAR2
1 Cross references
331 Possible Orthologues:

Fyn Related Src Family Tyrosine Kinase

Ensembl ID : ENSSVLG00005009937
Gene Symbol: FRK
1 Cross references
216 Possible Orthologues:

Galactosidase Alpha

Ensembl ID : ENSSVLG00005017941
Gene Symbol: GLA
1 Cross references
196 Possible Orthologues:

Galectin 1

Ensembl ID : ENSSVLG00005011367
Gene Symbol: LGALS1
1 Cross references
380 Possible Orthologues:

Galectin 3

Ensembl ID : ENSSVLG00005004351
Gene Symbol: LGALS3
1 Cross references
217 Possible Orthologues:

Gamma-Aminobutyric Acid Type A Receptor Subunit Alpha1

Ensembl ID : ENSSVLG00005019500
Gene Symbol: GABRA1
1 Cross references
202 Possible Orthologues:

Gamma-Aminobutyric Acid Type A Receptor Subunit Alpha2

Ensembl ID : ENSSVLG00005025024
Gene Symbol: GABRA2
1 Cross references
253 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).